Table 3.
Comparison in the collateral status of patients with occlusions in different arterial territories and their relationship to baseline characteristics.
| Variables | ICA | M1 Artery | Proximal M2 Artery | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Good (N = 4) |
Poor (N = 4) |
p-Value | Good (N = 13) |
Poor (N = 13) |
p-Value | Good (N = 9) |
Poor (N = 11) |
p-Value | ||
| Age (years) | 72.3 ± 16.1 | 76.5 ± 17.5 | 0.733 | 70.5 ± 9.6 | 58.9 ± 15.6 | 0.034 * | 70.4 ± 11.8 | 68.5 ± 11.7 | 0.711 | |
|
Male Sex
(n%) |
1 (25.0%) | 2 (50.0%) | 0.999 | 8 (61.5%) | 6 (46.2%) | 0.431 | 6 (66.7%) | 5 (45.5%) | 0.406 | |
|
Race
(n%) |
White/
Caucasian |
2 (50.0%) | 1 (25.0%) | 0.999 | 6 (46.2%) | 3 (23.1%) | 0.226 | 6 (66.7%) | 5 (45.5%) | 0.406 |
| African American/Black | 2 (50.0%) | 3 (75.0%) | 6 (46.2%) | 10 (76.9%) | 3 (33.3%) | 6 (54.5%) | ||||
| Asian | 0 (0.0%) | 0 (0.0%) | 1 (7.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | ||||
| BMI (kg/m2) | 39.7 ± 9.7 | 26.8 ± 3.9 | 0.049 * | 31.7 ± 14.6 | 25.0 ± 4.9 | 0.138 | 28.0 ± 8.6 | 27.8 ± 6.8 | 0.944 | |
| BMI grade | <30.0 | 1 (25.0%) | 4 (100.0%) | 0.143 | 8 (61.5%) | 11 (84.6%) | 0.378 | 6 (66.7%) | 6 (54.5%) | 0.670 |
| ≥30.0 | 3 (75.0%) | 0 (0.0%) | 5 (38.5%) | 2 (15.4%) | 3 (33.3%) | 5 (45.5%) | ||||
| Hemoglobin level (gm/dL) | 10.6 ± 3.9 | 13.1 ± 1.1 | 0.296 | 11.4 ± 2.0 | 12.5 ± 1.9 | 0.188 | 13.2 ± 1.7 | 13.3 ± 1.2 | 0.796 | |
| Hematocrit (%) | 33.4 ± 10.8 | 39.3 ± 3.5 | 0.363 | 35.6 ± 4.7 | 38.4 ± 5.4 | 0.170 | 41.9 ± 5.8 | 40.7 ± 3.2 | 0.563 | |
| WBC count (×103/mL) | 8.7 ± 3.3 | 9.1 ± 1.7 | 0.826 | 8.2 ± 2.9 | 9.0 ± 3.2 | 0.505 | 7.3 ± 0.9 | 9.8 ± 4.1 | 0.098 | |
| Platelet count (×103/mL) | 214.0 ± 52.4 | 233.8 ± 65.7 | 0.655 | 228.6 ± 65.7 | 238.8 ± 77.4 | 0.722 | 233.8 ± 109.0 | 258.5 ± 92.1 | 0.590 | |
| Platelet/WBC ratio | 26.5 ± 7.3 | 26.8 ± 11.0 | 0.968 | 29.9 ± 8.3 | 28.3 ± 9.5 | 0.652 | 32.8 ± 18.7 | 28.4 ± 11.6 | 0.528 | |
| Sodium level (mEq/L) | 143.5 ± 4.0 | 138.5 ± 3.0 | 0.094 | 138.6 ± 2.2 | 138.1 ± 3.1 | 0.619 | 140.2 ± 2.4 | 139.3 ± 3.6 | 0.512 | |
| Potassium level (mmol/L) | 4.1 ± 0.4 | 4.0 ± 0.4 | 0.675 | 4.1 ± 0.4 | 4.1 ± 0.7 | 0.764 | 3.9 ± 0.4 | 4.2 ± 0.4 | 0.218 | |
| Calcium level (mg/dL) | 8.5 ± 0.5 | 9.0 ± 0.4 | 0.165 | 8.9 ± 0.5 | 8.8 ± 0.7 | 0.717 | 8.6 ± 0.5 | 8.9 ± 0.5 | 0.283 | |
| Blood glucose level (mg/dL) | 124.5 ± 5.2 | 112.0 ± 11.3 | 0.092 | 118.7 ± 20.9 | 142.2 ± 102.7 | 0.428 | 141.3 ± 59.4 | 156.7 ± 72.2 | 0.614 | |
| BUN/creatinine | 21.0 ± 6.0 | 14.0 ± 8.0 | 0.212 | 18.8 ± 5.8 | 20.8 ± 10.8 | 0.576 | 18.3 ± 8.6 | 14.9 ± 4.9 | 0.277 | |
| SBP (mmHg) | 145.0 ± 5.4 | 163.8 ± 28.0 | 0.236 | 150.1 ± 23.8 | 138.2 ± 18.2 | 0.167 | 152.0 ± 26.7 | 150.0 ± 29.1 | 0.876 | |
| DBP (mmHg) | 79.5 ± 27.7 | 96.5 ± 17.2 | 0.337 | 80.3 ± 15.7 | 76.5 ± 21.6 | 0.616 | 93.1 ± 22.5 | 80.8 ± 16.8 | 0.178 | |
| HR (beat/minute) | 81.0 ± 3.8 | 85.5 ± 31.3 | 0.785 | 83.2 ± 12.6 | 78.7 ± 22.2 | 0.535 | 78.0 ± 20.7 | 80.1 ± 14.8 | 0.795 | |
| RR (cycle/minute) | 17.8 ± 4.0 | 17.3 ± 5.2 | 0.884 | 17.0 ± 2.2 | 18.2 ± 4.3 | 0.366 | 16.7 ± 2.4 | 18.3 ± 5.3 | 0.387 | |
| SpO2 (%) | 96.3 ± 5.7 | 97.0 ± 2.4 | 0.816 | 97.9 ± 2.5 | 98.3 ± 2.0 | 0.667 | 98.3 ± 3.0 | 98.0 ± 1.9 | 0.766 | |
| NIHSS score | 16.8 ± 5.0 | 18.8 ± 7.0 | 0.658 | 13.2 ± 8.1 | 17.6 ± 5.8 | 0.123 | 11.9 ± 9.4 | 14.4 ± 6.4 | 0.503 | |
|
Site
(n%) |
Right | 1 (25.0%) | 3 (75.0%) | 0.486 | 6 (46.2%) | 4 (30.8%) | 0.420 | 1 (11.1%) | 7 (63.6%) | 0.028 * |
| Left | 3 (75.0%) | 1 (25.0%) | 7 (53.8%) | 9 (69.2%) | 8 (88.9%) | 4 (36.4%) | ||||
| Hemorrhagic transformation (HT) within 48 H after MT, (n%) | 2 (50.0%) | 3 (75.0%) | 0.999 | 6 (46.2%) | 4 (30.8%) | 0.420 | 1 (11.1%) | 2 (18.2%) | 0.362 | |
* Statistically significant (<0.05).